Entering the era of precision medicine to treat amyotrophic lateral sclerosis
{{output}}
With the disease modifying therapy Qalsody (tofersen) which targets the RNA product of the SOD1 gene, having been shown effective in amyotrophic lateral sclerosis (ALS), the present perspective seeks to explore progress towards the implementation of precision ... ...
